 Biomarkers
"Biomarkers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.
| Descriptor ID |
D015415
|
| MeSH Number(s) |
D23.101
|
| Concept/Terms |
Biomarkers- Biomarkers
- Markers, Biological
- Biologic Markers
- Markers, Biologic
- Biologic Marker
- Marker, Biologic
- Marker, Biological
- Biological Marker
- Biological Markers
Serum Markers- Serum Markers
- Markers, Serum
- Marker, Serum
- Serum Marker
Surrogate Endpoints- Surrogate Endpoints
- Endpoints, Surrogate
- Surrogate End Points
- End Points, Surrogate
- Surrogate End Point
- End Point, Surrogate
- Surrogate Endpoint
- Endpoint, Surrogate
Viral Markers- Viral Markers
- Markers, Viral
- Viral Marker
- Marker, Viral
Biochemical Marker- Biochemical Marker
- Biochemical Markers
- Markers, Biochemical
- Marker, Biochemical
Markers, Immunologic- Markers, Immunologic
- Immune Markers
- Markers, Immune
- Marker, Immunologic
- Immunologic Markers
- Immune Marker
- Marker, Immune
- Immunologic Marker
Surrogate Markers- Surrogate Markers
- Markers, Surrogate
- Marker, Surrogate
- Surrogate Marker
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers".
This graph shows the total number of publications written about "Biomarkers" by people in this website by year, and whether "Biomarkers" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 | | 2002 | 0 | 3 | 3 | | 2003 | 0 | 2 | 2 | | 2004 | 0 | 2 | 2 | | 2007 | 0 | 1 | 1 | | 2008 | 2 | 0 | 2 | | 2010 | 0 | 5 | 5 | | 2011 | 3 | 4 | 7 | | 2012 | 0 | 10 | 10 | | 2013 | 0 | 6 | 6 | | 2014 | 2 | 8 | 10 | | 2015 | 1 | 7 | 8 | | 2016 | 1 | 6 | 7 | | 2017 | 0 | 5 | 5 | | 2018 | 1 | 5 | 6 | | 2019 | 1 | 2 | 3 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Biomarkers" by people in Profiles.
-
Dinh JC, Hosey-Cojocari CM, Jones BL. Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities. Paediatr Drugs. 2020 Feb; 22(1):55-71.
-
Li YH, Chen JW, Lin TH, Wang YC, Wu CC, Yeh HI, Huang CC, Chang KC, Wu CK, Chen PW, Huang CW, Chen ZC, Chang WT, Huang WC, Wang CY, Lee MY, Chao AC, Fu WR, Tsai LK, Tang SC, Chan HL, Yang YC, Wu YW, Hwang JJ, Lin JL. A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan. J Formos Med Assoc. 2020 Mar; 119(3):674-684.
-
Babar G, Clements M, Dai H, Raghuveer G. Assessment of biomarkers of inflammation and premature atherosclerosis in adolescents with type-1 diabetes mellitus. J Pediatr Endocrinol Metab. 2019 Feb 25; 32(2):109-113.
-
Rajpurkar M, Alonzo TA, Wang YC, Gerbing RB, Gamis AS, Feusner JH, Gregory J, Kutny MA. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631. J Pediatr Hematol Oncol. 2019 01; 41(1):51-55.
-
van Beers EJ, van Straaten S, Morton DH, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kwiatkowski JL, Rothman JA, Sharma M, Neufeld EJ, Sheth S, Despotovic JM, Kollmar N, Pospíšilová D, Knoll CM, Kuo K, Pastore YD, Thompson AA, Newburger PE, Ravindranath Y, Wang WC, Wlodarski MW, Wang H, Holzhauer S, Breakey VR, Verhovsek M, Kunz J, McNaull MA, Rose MJ, Bradeen HA, Addonizio K, Li A, Al-Sayegh H, London WB, Grace RF. Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study. Haematologica. 2019 02; 104(2):e51-e53.
-
Ng DK, Portale AA, Furth SL, Warady BA, Muñoz A. Time-varying coefficient of determination to quantify the explanatory power of biomarkers on longitudinal GFR among children with chronic kidney disease. Ann Epidemiol. 2018 08; 28(8):549-556.
-
Otto WR, Myers AL, LaRussa B, Kimberlin DW, Jackson MA. Clinical Markers and Outcomes of Neonates With Herpes Simplex Virus Deoxyribonucleic Acid Persistence in Cerebrospinal Fluid in Disseminated and Central Nervous System Infection. J Pediatric Infect Dis Soc. 2018 May 15; 7(2):e30-e33.
-
Rentea RM, Rentea MJ, Biesterveld B, Liedel JL, Gourlay DM. Factors Known to Influence the Development of Necrotizing Enterocolitis to Modify Expression and Activity of Intestinal Alkaline Phosphatase in a Newborn Neonatal Rat Model. Eur J Pediatr Surg. 2019 Jun; 29(3):290-297.
-
Victor TA, Khalsa SS, Simmons WK, Feinstein JS, Savitz J, Aupperle RL, Yeh HW, Bodurka J, Paulus MP. Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample. BMJ Open. 2018 01 24; 8(1):e016620.
-
Goyal A, Yeh A, Bush BR, Firek BA, Siebold LM, Rogers MB, Kufen AD, Morowitz MJ. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 01 18; 24(2):410-421.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|